Trial intelligence / Profile preview

Melatonin and Hyaluronic Acid for Chronic Periodontitis

NCT03656484Phase 2Completed

Sponsor
Concordia Dent
Start
Jan 2019
Primary completion
Dec 2019
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of Mucomel and hyaluronic acid sodium composite gel for injection in chronic periodontitis, sponsored by Concordia Dent. Primary endpoint: Clinical Attachment Level at 6 months. Started Jan 2019; status: completed.

02

Drugs

Mucomelhyaluronic acid sodium composite gel for injection
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT03656484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03656484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call